Consistent with the impact of TRAIL on formerly M2-polarized macrophages (Figure 9), TRAIL treatment slightly increased the expression of cell surface M1 markers in TAMs generated with the CM of three different tumor cell lines. The gene discussed is TNFSF10; the disease is neoplasm.